Seeing Is Believing

Currently out of the existing stock ratings of Paul Knight, 24 are a HOLD (12.77%), 164 are a BUY (87.23%).
Analyst Paul Knight, currently employed at KEYBANK, carries an average stock price target met ratio of 49.97% that have a potential upside of 44.08% achieved within 211 days.
Paul Knight’s has documented 350 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Basic Materials, Technology, Industrials sectors.
Most recent stock forecast was given on WST, West Pharmaceutical Services at 02-Jul-2026.
Analyst best performing recommendations are on CD (CHINDATA GROUP HOLDINGS LTD).
The best stock recommendation documented was for CYRX (CRYOPORT) at 1/19/2021. The price target of $75 was fulfilled within 3 days with a profit of $10.82 (16.86%) receiving and performance score of 56.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Jul-2026
$135
$-3.57 (-2.58%)
$180
21 days ago
(09-Jul-2026)
8/10 (80%)
$1.41 (1.06%)
237
Buy Since 06-Apr-2026
$148
$9.43 (6.81%)
$140
24 days ago
(06-Jul-2026)
7/10 (70%)
$17.4 (13.32%)
27
Buy Since 26-Feb-2026
$150
$13.99 (10.29%)
$145
1 months 6 days ago
(24-Jun-2026)
16/22 (72.73%)
$18.37 (13.96%)
122
Buy Since 02-Jun-2026
$155
$18.99 (13.96%)
$145
1 months 28 days ago
(02-Jun-2026)
9/13 (69.23%)
$19.95 (14.77%)
164
Buy Since 24-May-2023
$155
$18.99 (13.96%)
$165
2 months 2 days ago
(28-May-2026)
15/20 (75%)
$19.62 (14.49%)
249
Which stock is Paul Knight is most bullish on?
Which stock is Paul Knight is most reserved on?
What Year was the first public recommendation made by Paul Knight?